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Abstract
Background:  The problem of poor compliance/adherence to prescribed treatments is very complex. Health
professionals are rarely being asked how they handle the patient's (poor) therapy compliance/adherence. In this study,
we examine explicitly the physicians' expectations of their diabetes patients' compliance/adherence. The objectives of
our study were: (1) to elicit problems physicians encounter with type 2 diabetes patients' adherence to treatment
recommendations; (2) to search for solutions and (3) to discover escape mechanisms in case of frustration.
Methods: In a descriptive qualitative study, we explored the thoughts and feelings of general practitioners (GPs) on
patients' compliance/adherence. Forty interested GPs could be recruited for focus group participation. Five open ended
questions were derived on the one hand from a similar qualitative study on compliance/adherence in patients living with
type 2 diabetes and on the other hand from the results of a comprehensive review of recent literature on compliance/
adherence. A well-trained diabetes nurse guided the GPs through the focus group sessions while an observer was
attentive for non-verbal communication and interactions between participants. All focus groups were audio taped and
transcribed for content analysis. Two researchers independently performed the initial coding. A first draft with results
was sent to all participants for agreement on content and comprehensiveness.
Results: General practitioners experience problems with the patient's deficient knowledge and the fact they minimize
the consequences of having and living with diabetes. It appears that great confidence in modern medical science does not
stimulate many changes in life style. Doctors tend to be frustrated because their patients do not achieve the common
Evidence Based Medicine (EBM) objectives, i.e. on health behavior and metabolic control. Relevant solutions, derived
from qualitative studies, for better compliance/adherence seem to be communication, tailored and shared care. GPs felt
that a structured consultation and follow-up in a multidisciplinary team might help to increase compliance/adherence. It
was recognized that the GP's efforts do not always meet the patients' health expectations. This initiates GPs' frustration
and leads to a paternalistic attitude, which may induce anxiety in the patient. GPs often assume that the best methods to
increase compliance/adherence are shocking the patients, putting pressure on them and threatening to refer them to
hospital.
Conclusion: GPs identified a number of problems with compliance/adherence and suggested solutions to improve it.
GPs need communication skills to cope with patients' expectations and evidence based goals in a tailored approach to
diabetes care.
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Background
Diabetes mellitus type 2 is an important and increasing
health problem. In Belgium, the incidence is 231 new
cases per 100.000 inhabitants per year [1]. It is frequently
not diagnosed until complications appear, and approxi-
mately one-third of all people with diabetes may remain
undiagnosed. The estimated prevalence of diabetes
among adults was 7.4 % in 1995; this is expected to rise to
about 9 % in 2025 [2]. To date there is strong evidence
that vigorous treatment of diabetes type 2 can decrease the
morbidity and mortality of the disease by decreasing its
chronic complications [3-6]. However, poor patient com-
pliance/adherence to these treatment recommendations
can reduce therapeutic effects.
Earlier research on compliance/adherence showed that
neither the features of a disease, nor the referral process,
nor the clinical setting nor the therapeutic regimen seem
to influence compliance/adherence [7]. Because of the dif-
ficulties in measuring, no estimate of compliance/adher-
ence or non-compliance/non-adherence can be
generalized. Poor compliance/adherence is to be expected
in 30–50 % of all patients, irrespective of disease, progno-
sis or setting [8-10]. Today, more then 200 different doc-
tor- patient- and encounter-related variables have been
studied but none of them is consistently related to com-
pliance or fully predictive. Especially in quantitative stud-
ies, little attention has been paid to patients' ideas about
medicines and compliance/adherence. However, from
qualitative research we know that the most salient influ-
ences on compliance/adherence are patients' own beliefs
about medications and about medicine in general [7].
Their own knowledge, ideas and experiences, as well as
those of family members and friends, have also been
shown to correlate with compliance [11].
In order to understand and predict compliance/adher-
ence, the patients' attitude towards disease has been stud-
ied since more then twenty years by means of the health
belief model [12,13]. Today, new concepts of patient
involvement, participation and real partnership are intro-
duced [14]. Therapeutic interactions with patients should
not longer be viewed simply as opportunities to reinforce
instructions around treatment: rather, they should be seen
as a space where the expertise of patients and health pro-
fessionals can be pooled to arrive at mutually agreed goals
[15]. In primary care, patients strongly want a patient cen-
tered approach, with communication, partnership and
health promotion [16]. Evidence is increasing that involv-
ing patients more in consultations can increase compli-
ance/adherence to treatment.
Patients and caregivers interpret signs and signals in a dif-
ferent way [17]. These differences in perspective are not
inherently problematic. They frequently become so when
patients do not meet the goals and expectations of their
health care providers. In caregiver's point of view there is
an expectation that when they, as authoritative experts,
make recommendations, the patient only has the obliga-
tion to carry them out [18]. Furthermore, caregivers are
increasingly under pressure from health policy makers or
managed care organizations to reduce the costs of compli-
cations by rigorously complying with treatment
guidelines.
Physicians estimate their patients' compliance/adherence
to medications, and base decisions about treatment on
these estimates. Misjudgment of patient compliance/
adherence can have adverse consequences, including
withholding of therapy or unnecessary changes in ther-
apy. A review of the literature demonstrates that physi-
cians are often inaccurate in estimating patient
compliance/adherence with antiretroviral therapy [19]. In
the field of diabetes, medical anthropologists evaluated
an analytical framework for contrasting patient and pro-
vider goals and strategies [20]. This framework was
designed to allow examination of how a chronic illness
fits into both clinical and life-world contexts. By compar-
ing patients' and providers' goals, strategies and evalua-
tion criteria, a better understanding could be developed of
how recommended behavioral changes are understood
and applied differentially by each group. Using this
approach, certain shared outward semantic similarities
(i.e. "control") were found between patients' and provid-
ers' perspectives that obscured the presence of deeper dif-
ferences between those perspectives. The differences had
important implications for the long-term enactment of
diabetes self-care regimes.
The clinical literature on "non-compliance/non-adher-
ence" tends to problematize only the patient's perspective,
treating the provider's perspective as an uncontroversial
point of departure. Equal consideration is seldom given to
the role of provider perspectives and the broader institu-
tional and economic contexts of illness management [21].
Our work on compliance/adherence focusing on the pro-
viders' perspective, illustrates the difficulties Belgian GPs
experience in trying to help people with diabetes type 2
being adherent to treatment plans.
Methods
This descriptive qualitative study explores the thoughts
and feelings of GPs on patients' compliance/adherence. In
five focus groups (FG), GPs were asked how they think
their type 2 diabetes patients adhere to life style and die-
tary advices, medicine taking and management of the dis-
ease. We sounded out how GPs cope with conflicts
concerning these topics. In our analysis, we tried to
explore the barriers to compliance/adherence and possi-
ble solutions, GPs experience in diabetes management.BMC Family Practice 2005, 6:20 http://www.biomedcentral.com/1471-2296/6/20
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We also explored some coping mechanisms they use to
handle the conflict arising when patients do not heed
their advices.
The focus group technique used was based on a standard-
ized procedure, described in earlier publications [22-24].
After approval of the different local societies for primary
care and of the ethics committee of the study centre, all GP
members (n = 173) working in the surrounding munici-
palities of the study centre received a letter with some gen-
eral information on our project. Afterwards, physicians
were phoned to assess their interests in participating and
subscription in one of the discussion groups planned.
Forty interested physicians could be recruited and five
focus group sessions were organized. In compiling the dif-
ferent groups, no distinctions were made on age, gender
or number of years in practice in the hope of maximizing
interaction and outcome. Interested physicians could
make their choice between an afternoon and an evening
session. They also could choose between a venue on the
university campus or not. If after the five focus groups
content saturation was not achieved, additional focus
groups were planned.
A previous qualitative study on adherence to treatment
recommendations in patients living with diabetes [25]
revealed five different themes on the problem of compli-
ance/adherence. Together with the results of a compre-
hensive review of recent literature on adherence [26],
these themes were used to generate five open-ended core
questions (table 1) exploring the ideas and thoughts of
the participant GPs. The precise formulation of these
questions was discussed thoroughly by the research team
until mutual agreement and piloted in a first focus group.
A diabetes nurse, well-trained and experienced in conduc-
tion focus group discussions, moderated all focus groups,
guaranteeing a standardized procedure. She observed that
the level of involvement was as non-directive as possible,
Table 1: Focus group questions
Research questions:
FG Question 1 Introduction
• Do you as a physician have some insight in how your diabetes patients think about their illness and the treatment necessary to them?
FG Question 2 Health beliefs and advice giving
• In your treatment, you give many advices as on diet, walking, smoking cessation etc. Perhaps there is a good intention for it. However, can you 
tell us what you think your patients do with these advices?
• It might be possible that physicians do not understand enough the health beliefs of their patients when they give their advices. What do you 
think about this?
FG Question 3 Health beliefs on drug intake
• In addition, when you prescribe your medicines you have some expectations about your patients. What is your experience as to patients fulfill 
these expectations or not?
• Probably, patients have some alternative expectations. Do you notice that?
• It might be possible that physicians do not understand enough the health beliefs of their patients when they prescribe their medicines. What do 
you think about this?
FG Question 4 Health beliefs on follow up
• The guideline level on follow up of diabetes patients is not easy at all. Many examinations have to be performed; appointments have to be made 
to monitor the continuous changing risk profile of the diabetes patient. What do you think the diabetes patient expects from all this?
• It might be possible that physicians do not understand enough the health beliefs of their patients when they plan their follow up. What do you 
think about this?
FG Question 5 Coping with conflicts
• Sometimes, you certainly may not reach common grounds with your patients. How do you express these conflicts?
• How do you handle them?
• What solutions can you suggest?BMC Family Practice 2005, 6:20 http://www.biomedcentral.com/1471-2296/6/20
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but meanwhile trying to collect as much data as possible,
ensuring that the desired set of topics was covered and
encouraging the participation of everyone [27,28].
An observer (JW) gathered information on the non-verbal
communication and on the interaction between partici-
pants. In this way, special attention could be given in the
analysis, to those pronouncements and text fragments
where verbal and non-verbal consensus existed. The dura-
tion of the discussions was limited to two hours.
At the end of every focus group, there was a debriefing
between moderator and observer to discuss the most
important themes and possible differences with other
focus groups. Since participants of FG 5 added no new
information anymore, content saturation was supposed
to be reached.
The first focus group served as a pilot. Since no indistinct-
ness with regard to the questioning or other procedures
were allocated, and since the results were very similar to
the other focus group interviews we decided to keep these
first results in the analyzing process. In no focus group,
any striking nuisance cases were present.
All focus groups were audio taped and transcribed for con-
tent analysis.
Two researchers (JW and EV) independently performed
the initial coding. In the case of disagreement, a solution
was found by clarifying individually the meaning of a
code and discussing until mutual consent was reached.
We defined the different themes and performed cross-ref-
erencing within the different coding categories, and by
text word search in the document or selected sections of it.
In doing so, we clarified ideas, discovered further themes,
searched for patterns and explored participants' explana-
tory models.
A first draft with results was sent to all participants for
agreement on content and comprehensiveness (response
rate 72.5 %). This participant checking leaded to only a
few interpretative comments. We added or corrected most
of them in the draft after discussion and agreement with
the moderator.
Results
Of the 173 GPs contacted, 61 agreed to participate (35.3
%), and 40 GPs (23.1 %) attended the focus groups. Phy-
sician and practice characteristics are summarized in table
2.
Content analysis of the text fragments resulted in primary
codes, which after an inductive interpretation and catego-
rization process could be structured in three themes (table
3): barriers to patient's compliance/adherence as experi-
enced by the GPs; solutions as used by the GPs to increase
their patients' compliance/adherence and coping mecha-
nisms used by the GPs.
Barriers to compliance/adherence
With regard to compliance/adherence, GPs recognized
two kinds of patients: "motivated" patients and "not-to-
be-motivated" patients. The "good" patients were very
motivated, they did their best and they almost
meticulously followed their regimens. The "bad" patients
were hardly to be motivated, they thought they have eve-
rything under control but they were neglectful which was
frustrating for the GP.
M. I think you can hardly speak about "the" diabetes patients;
at least this is what I see in my surgery. You have people who
are very conscious of their illness, they really take care and on
the other hand, there are the ones who neglect everything. I bet
everybody here knows these kinds of patients [general agree-
ment]. So, all these different people have a different attitude
towards their disease and their treatment in general.
Table 2: physician and practice characteristics
FG 1 FG 2 FG 3 FG 4 FG 5 Total
N1 0 7 9 8 6 4 0
 /  7 / 3 4 / 3 6 / 3 4 / 4 5 / 1 26 / 14
Mean age (S.D.) 44.8 (9.8) 47.9 (11.8) 48.6 (9.0) 38.4 (5.8) 47.5 (15.3) 45.3 (10.5)
mean years in practice (S.D.) 18.1 (9.9) 21.9 (11.4) 20.5 (8.4) 12.5 (5.9) 19.2 (16.2) 18.4 (10.3)
Solo (%) 70 71 67 88 67 73
N = number of participants
S.D. = standard deviationBMC Family Practice 2005, 6:20 http://www.biomedcentral.com/1471-2296/6/20
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Though they know it is an important challenge and duty,
GPs were convinced that it is very difficult to motivate
their patients to adhere to treatment regimens. They con-
sidered barriers for compliance/adherence on three differ-
ent levels: the patient, the GP and the care model in which
the treatment is offered.
The patient
At the patient's level, their GPs identified important barri-
ers such as social isolation and deficient knowledge of dia-
betes. They also remarked that diabetes patients tend to
minimize their disease. This really is in contrast with the
GP's objectives.
F. I believe patients often do underestimate diabetes [general
agreement of the group]. The patients think it is an infirmity
of old age, an age disease. Consequently, they are not motivated
to follow strictly their diet and therapy. That is my conclusion
after 30 years of practice.
GPs acknowledged the kind of problems patients have
with the treatment regimen and realized that a lifestyle
change is not that simple. Yet, they felt the patient's oppo-
sition by lots of excuses for preservation of non-healthy
habits.
On the other hand, some patients have learned to rely on
modern medicine that offers medication for every com-
plaint. To take that medicine is easier and fits better in our
way of life than to part with dietary habits linked to the
patient's cultural environment.
P. If you feel ill, then you take a pill... anyway, there are drugs
for all complaints.
The general practitioner
GPs quickly begin to feel powerless once they experience
that patients do not attain the EBM treatment goals. This
has a negative impact on further promotion of compli-
ance/adherence to proposed regimens. GPs cherish high
expectations concerning metabolic results in their diabe-
tes patients, but do not succeed in communicating this to
their patients. Few GPs liked to repeat time and again the
same messages, they didn't like to "nag" or "tease" as it is
mentioned in one of the focus groups, as this simply leads
to frustration.
W. Of course we must ask ourselves if we are doing the right
thing. Is it really so bad to give a pill when the patient is satis-
fied, when the sugar levels are OK and the HbA1c is good, but
when the patient doesn't strictly follow his diet. What do we
have to do then?
B. When the patient persists in neglecting his treatment, I give
up...
The care model
With regard to diabetes care, the Belgian health care sys-
tem uses a convention system in which intramural (sec-
ondary care) centers arrange with the National Institute
for Disease and Disability Insurance (RIZIV/INAMI) to
refund well-defined diabetes care to specific patients. To
be considered for this care, at least two insulin injections
a day are required. On this condition, patients have a right
to free dietary advice and diabetes education and free (but
limited) materials for self-monitoring.
For all other diabetes patients, mostly treated in primary
care, currently there is no reimbursement for education or
self-monitoring of blood glucose. The GP felt that his
good relationship with the patient is threatened by this
inequality, because others can offer their patients advan-
tages that they as GPs cannot give. In the GPs opinion, this
interference in the relationship of trust could hinder the
compliance/adherence. The superior position of the free
Table 3: Themes, categories and codes.
Theme code
Barriers to adherence
Patient Categorical approach
Social isolation
Deficient knowledge of diabetes
Minimising of the disease
Opposition to change
'Modern' medicine
Physician Choosing the easiest way
Supposed lack of respect
Model of health care No repayment for self-monitoring
Lack of multidisciplinary support
Solutions
Communication Evaluate knowledge
Give information
Repeat
Control how it can be achieved
In the patient's language
Work in a structured way Make appointments
Standardized educational packages
Structured file administration
Shared care Multidisciplinary teams
Identical messages
Coping mechanisms
Physicians Directing /paternalistic attitude
Induction of guilt and fright
Patients Discussed decision-makingBMC Family Practice 2005, 6:20 http://www.biomedcentral.com/1471-2296/6/20
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accessible "specialist", who may have another message for
the patient, also gave many GPs a bad feeling.
P. Our experience points out that some of these centers take over
the care of patients and that we never see those patients again.
We still get reports and results of blood tests on a regular base
but we do not see the patient any more...
Poor co-operation between intra-mural diabetes centers
and the GPs divides the care process between different
partners ignoring each other's efforts and responsibilities.
Moreover, in the system of fee-for-service the GP often has
to go along with the expectations of the patient in order to
keep him in his surgery and to protect his income. This
made the physician thinks his patients do not appreciate
his specific expertise and skills, which again may result in
frustration and even anger.
G. Get angry ... [sigh], but afterwards I feel so frustrated. Get
angry with somebody to whom you could have explained in an
adult way, "this is becoming impossible", "I do it this way,
that's my routine and we'll try stick to it." When I get angry, it
is on my mind for the rest of the day...
Solutions
Solutions were identified in three categories. Core ele-
ments hereby are: communication, tailored care and
shared care.
Communication
GPs realized they have opportunities for communication
with the patient. They knew it is wise to check first what
the patient already knows, in order to give further relevant
information, taking into account the patient's ability to
assimilate the messages. GPs should repeat information,
check the understanding; explore the patients' own
thoughts about and the willingness to apply them.
Doing so, GPs should be careful not to overload patients
with information and not to keep "harping on" about
health advice that does not (yet) interest the patient.
A. I wonder if you haven't to be careful with those explanations.
You see, if each time you give a flow of information, you'll make
the patient sick with it ... He'll get demotivated, especially
when, after a blood sample, showing a bad result while the
patient himself thinks he has done his best. You must not exag-
gerate in trying to give advice.
Tailored care
GPs considered that the way in which a consultation is
carried out could also stimulate compliance/adherence.
Important factors seen as able to increase compliance/
adherence were scheduled consultations and teamwork. It
should give the patient a better notion of "care giving"
when a structured diabetes consultation model is
adopted. This, together with consultation hours by
appointment give patients a feeling of more time being
spent and of more experience being applied on his/her
behalf. GPs thought that standardized education tools
and a structured diabetes file could improve compliance/
adherence compared with an "ad hoc" consultation in
which the GP only tends to go along with patients' com-
plaints and questions.
B. I think it's partly our fault. I have the impression I cannot
follow up so easily and I feel you do it in a more structured way.
It all depends on that. So "How does one handle it, how can one
work in a structured way on his own?" If you do so, the patient
follows. In my case, it is not very structured so far and I don't
follow up very well. Therefore, my patients don't do it either. I
think that can make a difference when you handle it profession-
ally and structured.
Shared care
GPs considered that working in a multi disciplinary team
might encourage better compliance/adherence. They
believed that dieticians could give more adequate and
more varied food advice than they could themselves.
When they succeeded in referring the patients to the dieti-
cian, the majority of patients were very satisfied, but the
first step remained difficult.
T. I find out that it's not sufficient when we give advice. That's
why I usually send the patients, as soon as possible, to the dia-
betic dietician who gives them explanations. When 2 or 3 peo-
ple co-operate, it works better. The patients follow up more
strictly then when a doctor works on his own. A doctor might
also give a leaflet about diabetes, the patients read it but next
time, they have forgotten everything about it. They put it some-
where, stuffed away in a drawer. When a dietician sees the
patient, he asks what he eats. All that practical information
makes a stronger impression than the physician's advice.
Besides, I don't have enough time to give such detailed
explanations.
Coping mechanisms
GPs often become directing and paternalistic in order to
cope more easily with the above-mentioned barriers. This
attitude may induce guilt and anxiety in the patients. Phy-
sicians assumed that shocking the patients, pressuring and
threatening to send them to the hospital were often the
only effective methods to improve compliance/adher-
ence.
W. It all depends on the characters, you see. You have people
who never feel responsible; they always put the blame on some-
body else, despite all your explanations. If something bad hap-
pens, they'll tell you you've never explained enough, never
emphasized enough or never frightened them enough. Because,BMC Family Practice 2005, 6:20 http://www.biomedcentral.com/1471-2296/6/20
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you say sometimes "You should not frighten them." However,
for some people the only option is to make them afraid. Other-
wise, they won't do it and then they blame you for not doing it...
In this way, GPs tighten a net around the patient, restrict-
ing his/her freedom of movement. An indication of this
restriction can be found in the explicit request for a more
tailored care system. In emphasizing this, doctors may
minimize their own responsibility and try to shift the
blame to the liberal marginal conditions in which they are
functioning.
Physicians also considered that patients take refuge
behind different reasons in an argued decision, such as
cultural motives (for example dietary tradition), financial
problems (lack of reimbursement) and strict personal rea-
sons to avoid compliance/adherence. They viewed the
motives of patients as deep-rooted and difficult to modify.
Discussion
Many patients for whom diabetes medication is pre-
scribed are poor compliers with treatment, including both
oral medication and insulin [29]. In these exploratory
focus groups, we discover barriers and solutions for opti-
mal compliance/adherence in people living with diabetes
type 2, seen by Belgian GPs.
From the dynamic discussions in the focus groups, we
may conclude that this subject was of substantial concern
to GPs. There was a constructive mutual interaction and
good co-operation in all five focus groups. Open discus-
sions went along with a positive willingness to participate
in the debate.
From the GPs' point of view, an inventory could be made
of the different barriers and solutions that matter for com-
pliance/adherence of their diabetes patients. This inven-
tory is far from complete. Besides, it was not the intention
of this study to make out an exhaustive list of all kinds of
compliance/adherence barriers. In this article, we confine
ourselves to the viewpoint on compliance/adherence by
diabetes patients, as experienced by the GP.
We learn that GPs take a shot at the patients, complaining
their deficient knowledge, the fact they minimize diabetes
related problems and their blind confidence in medicine.
GPs also blame the health care system in which they feel
as inferior doctors in comparison with specialists, widely
accessible for patients. Taken together, these externalizing
factors seem to lead to a profound defeatism. Where the
GP tries to give "good" diabetes care by strictly promoting
evidence-based diabetes objectives, the patients' "failing"
frustrates him. Besides, they recognize the lack of effective
communication tools for making the patient a real partner
in their decisions.
Probably, GPs feel inclined to allocate the extent of some-
one's responsibilities too fast. Perhaps, they take too
much personal responsibility and focus too much on
evidence based medical treatment options wherefore they
are real experts and responsible for. A failing in reaching
these treatment goals then is a failing of the doctor-expert
himself who is doing the best he can. Lifelong guidance of
chronic ill patients as is the case in diabetes, asks for
shared responsibilities where going about with the disease
(behavioral changes, compliance/adherence attitudes, ...)
is the patient's responsibility. New essential skills and
attributes for a health care provider to promote behavioral
change and risk reduction are skills for assessing readiness
for behavioral change, relationship building skills, and
skills in considering the patient's attitudes and beliefs
about the disease or treatment involved [30]. Motiva-
tional interviewing, characterized by its empathic non-
confrontive style, assists movement through the stages of
change to the "action" stage where engaging in change
behavior begins. It is designed to assist clients (patients)
in exploring and resolving ambivalence to increase moti-
vation for change. Physicians can use the model to inter-
vene successfully at all different levels of behavioral
change, where patients are helped by the model to take
responsibility for changing habits [31].
Lacking these skills of motivational counseling and shared
decision making, the best method to promote patient's
compliance/adherence is assumed to be using shock tac-
tics. Identical conclusions were found in a Polish study
were doctors, when confronted with non-compliance,
also applied certain tactics of doubtful effectiveness which
might worsen the patient's emotional state or harm his as
a person. Valuable techniques of proven efficacy were not
used [32].
Tailored and shared care is considered as a possible solu-
tion for better compliance/adherence of diabetes patients.
From GPs point of view, this long for teamwork fits with
emerging international evidence stating that structured
[33] and patient oriented [34] care result in better out-
comes. This new model of care fits quite well with our
medical paradigms, but might be too much adaptedto the
caregivers, without taking into account the views and pri-
orities of (chronic) patients. It remains to be seen if struc-
tured care can also deliver a better long term care of
patients with chronic illnesses. Don't we forget the patient
in organizing shared care?
The cornerstones of health care to support active patient
participation are to guarantee the continuity of care, to
integrate education in health care and to encourage the
patient's attendance [35]. An increased patient satisfac-
tion may be contributing to improved clinical outcomes
[36]. However, the relation between patients' satisfactionBMC Family Practice 2005, 6:20 http://www.biomedcentral.com/1471-2296/6/20
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and GPs patient-centered behaviors remains unclear [37].
There is also limited and mixed evidence on the effects of
patient centered interventions on patient health care
behaviors or health status; or on whether these interven-
tions might be applicable to providers other than physi-
cians as diabetes-specialized nurses [38]. Professionals
committed to achieving the benefits of patient centered
consulting should take care not to lose the focus on dis-
ease while paying attention to the unique experience of
illness of each patient [39]. Enhancing patient-provider
agreement on both overall treatment goals and specific
strategies to meet these goals may lead to improved
patient outcomes [40].
Until now, little research has being done on the relation-
ship between health care provider and compliance/adher-
ence. For HIV patients, better treatment adherence is
reported in those patients who perceived themselves to be
more engaged with their health care provider [41]. How-
ever, since self-reported measures were used, this finding
should be viewed with caution. Also in antidepressant
treatments, the physician's attitude about the medication
is a key factor for improving compliance [42].
A Canadian study on the role of patient, physician and
system factors in the management of type 2 diabetes
patients [43] shows very striking similarities with our
study on compliance/adherence. Canadian GPs also
believe that early educational interventions for patients
with diabetes resulted in better outcomes. They also
described the diabetes educational centers as a valuable
resource and stressed the importance of referring the
patient soon after diagnosis. In Canada, time and physi-
cian remuneration were identified as the main health sys-
tem barriers to optimal diabetes management.
Qualitative research is often deemed to have lower relia-
bility compared with experimental research. Yet, it has
strong face validity, especially when it includes an obser-
vational component that enables the researcher to com-
pare oral statements with actual practice [44]. In all our
focus groups, all participating GPs spoke very spontane-
ous in an open atmosphere without any verbal aggression.
However, in answering the questions, there was a clear
sound of frustration in all five focus groups. Probably,
that is a reason why some of the quotes sound rather puni-
tive and blaming of patients. We never had the feeling that
GPs were "set up" to respond in such a way. They react
defensively because they feel powerless. They are afraid of
decreasing income and standing by loosing patients in a
fee-for-service payment with free entrance to all levels of
care.
At least some limitations to our study have to be
considered.
First, the topic of interest. Research in such a complicated
matter as compliance/adherence is extremely difficult and
always fragmentary, especially given the lack of a specific
model or general theory. Different authors use "compli-
ance", "concordance" and "adherence" haphazardly,
complicating a comprehensive study of the literature [26].
Additional, for instance in Dutch, the three different
meanings of compliance, concordance and adherence are
interpreted only by one word. Though we presume in this
context that "compliance" (doing what is told to be done)
is the best translation, we prefer to use the combined term
"compliance/adherence".
Second, the sampling. The participating GPs in this study
were all volunteering and interested in a discussion on
"problems diabetes patients might have to follow treat-
ment recommendations", as mentioned in the
introduction letter. Perhaps, volunteering GPs are more
willing to discuss these difficult problems in the patient
provider interaction. Since our sample fits well with age,
gender and practice organization (table 2) of the Flemish
GP population, we assume having described a maximal
variation of answers. Besides, the main goal of our study
was not to generate conclusions that could be generalized,
but to explore and gain a deeper understanding of the GPs
perspective of patient compliance/adherence. This limita-
tion should also be taken into account by interpreting the
results and before transferring the conclusions to other
contexts. It could be argued that selecting GPs in different
focus groups according to gender or experience could have
been a more appropriate approach. The number of years
in practice might be influence frustration. However, the
provoked diversity of the group was meant to elicit a rich
dynamic interaction in the conducted conversation.
Third, the analysis. While looking for barriers and solu-
tions in patients' adherence GPs' frustration is an impor-
tant issue in our results. GPs feel as if the patient does not
consider them capable to treat their illness. However, a
recent and extensive health inquiry in Belgium confirms
the people's confidence in general medicine [45]. More,
patients' own choice of a primary care physician seems to
be associated with better adherence to their treatment
regimes [46]. This relationship even remained significant
after controlling for possible confounding factors as phy-
sician gender, patient gender or length of relationship.
Perhaps GPs underestimate their potential value and the
effect they can achieve with their patients. Rather than
reflecting on themselves and making themselves familiar
with newer communication skills, GPs shift the blame of
failing on an inappropriate system or other extrinsic fac-
tors (e.g. cultural and social problems).
Patients, especially those with chronic illness, make deci-
sions about treatments that fit with their own beliefs andBMC Family Practice 2005, 6:20 http://www.biomedcentral.com/1471-2296/6/20
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personal circumstances. They may have clear reasons, nar-
rowly related to their health beliefs, for adhering or not
adhering to treatment recommendations.
The shared decision making process is rather complex. A
joint patient-provider perspective is needed. Health care
professionals should assess patients' reasons and beliefs
in order to achieve agreement on attainable treatment
goals. They need to shift the emphasis away from attempt-
ing to directing patients into take the medication they pre-
scribe, towards learning how they can contribute to the
decisions that patients currently make about their medica-
tions [47].
Adherence to treatment is therefore the shared responsi-
bility of patients and GPs. In complex treatment plans, as
is the case in diabetes, a possible way of helping people
being adherent perhaps is helping them making more
explicit their own attainable priorities. Exploring thepa-
tient's expectations towards the disease and its treatment
and translating these individual expectations to realizable
and realistic objectives for the patient and in concert with
the patient, is an important communication task for the
GP. In fact, it is patients who should be the primary actors
in medical decision-making, and the health professionals
should adopt a supportive role. This joint patient-pro-
vider interaction could be a real contribution to a more
positive approach on diabetes care. It will help patients to
set their own desirable goals and give the GPs' consult
again more value and depth. . In essence, then, compli-
ance is an elusive, flexible goal.
Conclusion
The patient's own expectations with regard to illness and
health not always correspond to the objectives and expec-
tations of the physician's treatment proposals. The moti-
vation of the physician to achieve a good result may be in
conflict with the patient's own motivation to lead his own
life. GPs seem to be in need of communication skills to
integrate the various expectations of physicians and
patients regarding diabetes care.
Our findings suggest a necessary shift to a model of
patient-provider-partnership with mutual agreement on
shared decisions. A closer relationship wherein the patient
is more engaged to his treating GP possibly could reduce
frustration.
Shared care, referred by these GPs as a possible solution
for better compliance/adherence, only can fulfill these
purpose if, from the beginning, the patients' perspectives
and concerns are not forgotten.
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